A combination therapy is being developed that could benefit patients with treatment-resistant acute lymphoblastic leukaemia (ALL), US scientists have reported.
The treatment, developed by Dr Reshmi Parameswaran and colleagues at Case Western Reserve University in Ohio, USA, is based attracting natural killer (NK) cells in the immune system to destroy cancer cells.
New immune therapies have helped improve survival rates for acute lymphoblastic leukaemia. However, there are still patients whose cancer is unresponsive to treatment or suffer from drug-related toxicities or drug resistance.
In the study, the team tested an antibody which rapidly recruits NK cells to attack ALL cells. The antibody binds to a protein on the su...
1 day ago
A combination therapy is being developed that could benefit patients with treatment-resistant acute lymphoblastic leukaemia (ALL), US scientists have reported.
The treatment, developed by Dr Reshmi Parameswaran and colleagues at...
1 day ago
Scientists have discovered a new property of acute myeloid leukaemia (AML) cells, which could guide future treatment strategies.
Dr Ross Dickins of Monash University, Australia, together with several international collaborators,...
4 days ago